Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Opko Health, Inc. (NASDAQ: OPK) stands prominently in the healthcare sector, specifically within the diagnostics and research industry. Despite its current challenges, including a significant decline in revenue, the company..
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors interested in the healthcare industry. Based in Princeton, New Jersey,..
Harrow, Inc. (NASDAQ: HROW) stands out as a compelling opportunity within the healthcare sector, specifically in the niche of ophthalmic pharmaceuticals. With its roots dating back to 1998 and a..
MannKind Corporation (MNKD), a biopharmaceutical company specializing in treatments for endocrine and orphan lung diseases, is generating considerable attention in the healthcare investment sector. With a market capitalization of $1.08..
Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the healthcare sector, provides essential management and operational services to medical care facilities across the United States. With a market..
Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, is making waves with its innovative approach to drug development, particularly in the fields of oncology and immunology. Headquartered..
AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 39.19% based on the average..
For investors with an eye on the dynamic healthcare sector, Evotec SE (EVO) presents an intriguing prospect. As a prominent player in the drug discovery and development industry, Evotec’s global..
For investors navigating the dynamic landscape of the biotechnology sector, Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents an intriguing opportunity, with analyst ratings suggesting a potential upside of 167.92%. As a..
Establishment Labs Holdings Inc (NASDAQ: ESTA) stands out as a significant player in the healthcare sector, particularly within the medical devices industry. Headquartered in Alajuela, Costa Rica, this company has..
For investors seeking opportunities in the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents a compelling case with its promising growth prospects and strong analyst ratings. Specializing in home..
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a key player in the biotechnology sector, is making waves with its innovative approach to treating rare diseases. Headquartered in Durham, North Carolina, this company..
Schrödinger, Inc. (NASDAQ: SDGR) is carving out a significant niche within the healthcare sector, specifically in the health information services industry. With a market capitalization of $1.51 billion, Schrödinger offers..
Arrowhead Pharmaceuticals, Inc. (ARWR), a key player in the biotechnology sector, has captured investor attention with its promise of significant upside potential. Based in Pasadena, California, Arrowhead is dedicated to..
Evolent Health, Inc. (NYSE: EVH), a prominent player in the Health Information Services industry, is capturing investor attention with a compelling potential upside of 29.53%, according to recent analyst ratings...
Teladoc Health, Inc. (NYSE: TDOC), a pioneer in virtual healthcare services, has captured the attention of investors with its potential for a 11.20% upside, despite the challenges reflected in its..
Surgery Partners, Inc. (NASDAQ: SGRY) has been steadily carving out a significant niche in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.82..
NovoCure Limited (NASDAQ: NVCR) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Baar, Switzerland, NovoCure is at the forefront of developing innovative..
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is making waves in the healthcare sector, specifically within the drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. With a market capitalization of..
89bio, Inc. (NASDAQ: ETNB) is emerging as a compelling opportunity in the biotechnology sector, captivating investors’ attention with its promising upside potential of 188.20%. As a clinical-stage biopharmaceutical company, 89bio..
